sensus healthcare inc - SRTS

SRTS

Close Chg Chg %
3.70 0.28 7.57%

Closed Market

3.98

+0.28 (7.57%)

Volume: 176.70K

Last Updated:

Dec 31, 2025, 4:00 PM EDT

Company Overview: sensus healthcare inc - SRTS

SRTS Key Data

Open

$3.71

Day Range

3.65 - 4.00

52 Week Range

3.03 - 9.08

Market Cap

$65.37M

Shares Outstanding

16.43M

Public Float

14.73M

Beta

1.22

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.18

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

68.64K

 

SRTS Performance

1 Week
 
5.01%
 
1 Month
 
2.05%
 
3 Months
 
16.03%
 
1 Year
 
-42.49%
 
5 Years
 
3.11%
 

SRTS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About sensus healthcare inc - SRTS

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

SRTS At a Glance

Sensus Healthcare, Inc.
851 Broken Sound Parkway North West
Boca Raton, Florida 33487
Phone 1-561-922-5808 Revenue 41.81M
Industry Medical Specialties Net Income 6.65M
Sector Health Technology 2024 Sales Growth 71.305%
Fiscal Year-end 12 / 2025 Employees 54
View SEC Filings

SRTS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 17.032
Price to Sales Ratio 2.708
Price to Book Ratio 2.045
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 10.767
Enterprise Value to Sales 2.195
Total Debt to Enterprise Value 0.007

SRTS Efficiency

Revenue/Employee 774,203.704
Income Per Employee 123,092.593
Receivables Turnover 2.119
Total Asset Turnover 0.721

SRTS Liquidity

Current Ratio 9.641
Quick Ratio 7.357
Cash Ratio 3.748

SRTS Profitability

Gross Margin 58.438
Operating Margin 19.351
Pretax Margin 21.58
Net Margin 15.899
Return on Assets 11.469
Return on Equity 12.701
Return on Total Capital 11.779
Return on Invested Capital 12.582

SRTS Capital Structure

Total Debt to Total Equity 1.078
Total Debt to Total Capital 1.067
Total Debt to Total Assets 0.968
Long-Term Debt to Equity 0.713
Long-Term Debt to Total Capital 0.705
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Sensus Healthcare Inc - SRTS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
27.04M 44.53M 24.41M 41.81M
Sales Growth
+182.37% +64.68% -45.20% +71.31%
Cost of Goods Sold (COGS) incl D&A
10.05M 14.90M 10.35M 17.38M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
613.00K 315.00K 412.00K 432.00K
Depreciation
509.00K 219.00K 412.00K 432.00K
Amortization of Intangibles
- - 104.00K 96.00K
-
COGS Growth
+132.31% +48.24% -30.59% +67.97%
Gross Income
16.99M 29.63M 14.06M 24.43M
Gross Income Growth
+223.64% +74.41% -52.54% +73.76%
Gross Profit Margin
+62.82% +66.53% +57.61% +58.44%
2021 2022 2023 2024 5-year trend
SG&A Expense
12.87M 14.80M 14.44M 16.34M
Research & Development
3.44M 3.46M 3.68M 4.22M
Other SG&A
9.43M 11.34M 10.76M 12.13M
SGA Growth
-4.56% +14.99% -2.40% +13.15%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
4.12M 14.83M (382.00K) 8.09M
Non Operating Income/Expense
1.00K 13.16M 1.03M 932.00K
Non-Operating Interest Income
2.00K 382.00K 992.00K 932.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 2.00K 2.00K
-
Interest Expense Growth
- - -85.95% -100.00%
-
Gross Interest Expense
- - 2.00K 2.00K
-
Interest Capitalized
- - - -
-
Pretax Income
4.12M 27.99M 652.00K 9.02M
Pretax Income Growth
+160.26% +579.53% -97.67% +1,283.74%
Pretax Margin
+15.23% +62.85% +2.67% +21.58%
Income Tax
- 3.75M 167.00K 2.38M
Income Tax - Current - Domestic
1.10M 1.95M 594.00K 2.43M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.10M) 1.85M (427.00K) (57.00K)
Income Tax - Deferred - Foreign
- - - (55.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
4.12M 24.24M 485.00K 6.65M
Minority Interest Expense
- - - -
-
Net Income
4.12M 24.24M 485.00K 6.65M
Net Income Growth
+160.26% +488.59% -98.00% +1,270.52%
Net Margin Growth
+15.23% +54.44% +1.99% +15.90%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
4.12M 24.24M 485.00K 6.65M
Preferred Dividends
- - - -
-
Net Income Available to Common
4.12M 24.24M 485.00K 6.65M
EPS (Basic)
0.25 1.471 0.0298 0.4075
EPS (Basic) Growth
+160.11% +488.40% -97.97% +1,267.45%
Basic Shares Outstanding
16.48M 16.48M 16.26M 16.31M
EPS (Diluted)
0.2496 1.4589 0.0298 0.4063
EPS (Diluted) Growth
+160.01% +484.50% -97.96% +1,263.42%
Diluted Shares Outstanding
16.50M 16.62M 16.27M 16.36M
EBITDA
4.73M 15.15M 30.00K 8.52M
EBITDA Growth
+163.01% +220.01% -99.80% +28,306.67%
EBITDA Margin
+17.50% +34.01% +0.12% +20.38%

Snapshot

Average Recommendation BUY Average Target Price 7.50
Number of Ratings 3 Current Quarters Estimate -0.057
FY Report Date 03 / 2026 Current Year's Estimate -0.06
Last Quarter’s Earnings -0.06 Median PE on CY Estimate N/A
Year Ago Earnings -0.343 Next Fiscal Year Estimate 0.135
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 2
Mean Estimate -0.06 -0.02 -0.06 0.14
High Estimates -0.03 0.04 0.18 0.22
Low Estimate -0.07 -0.06 -0.20 0.05
Coefficient of Variance -40.75 -236.04 -348.01 89.04

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 4
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Sensus Healthcare Inc - SRTS

Date Name Shares Transaction Value
Dec 18, 2025 Michael J. Sardano PRESIDENT AND GENERAL COUNSEL; Director 158,839 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Nov 21, 2025 Eric Sachetta Director 133,113 Open market or private purchase of non-derivative security Non-derivative transaction at $4.5 per share 599,008.50

Sensus Healthcare Inc in the News